Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.5 USD | +1.73% | +4.29% | +33.31% |
04-19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
04-01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.31% | 2.32B | |
+11.99% | 3,096B | |
+12.19% | 85.37B | |
+6.94% | 77.1B | |
-13.71% | 54.31B | |
-22.68% | 47.92B | |
+24.94% | 47.74B | |
+19.22% | 42.15B | |
+69.42% | 38.06B | |
-9.14% | 24.73B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Deutsche Bank Adjusts Cellebrite's Price Target to $7 From $10, Maintains Buy Rating